# Role of Topical Putrescine (Fibrostat) for Prevention of Hypertrophic Scars in Mammoplasty Patients

> **NCT03376620** · PHASE3 · COMPLETED · sponsor: **University of Manitoba** · enrollment: 56 (actual)

## Conditions studied

- Hypertrophic Scar

## Interventions

- **DRUG:** 1,4-Diaminobutane
- **DRUG:** 10% Urea cream

## Key facts

- **NCT ID:** NCT03376620
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09-02
- **Primary completion:** 2013-08-13
- **Final completion:** 2016-07-15
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2017-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03376620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03376620, "Role of Topical Putrescine (Fibrostat) for Prevention of Hypertrophic Scars in Mammoplasty Patients". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT03376620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*